Medaxion LLC is a mobile health company based in Nashville, Tennessee, that specializes in simplifying administrative processes and creating a communication and information stream for anesthesia practices. Their flagship product, Pulse, is an iPhone platform that allows anesthesiologists to enter billing data at the point of care. It also includes cloud software that enables anesthesia practice administrators to aggregate information from individual practitioners.
The Pulse platform offers several key features, including point-of-care charge capture, broadcast status, practice activity oversight, and billing system integration. These features aim to make scheduling and communication more efficient while reducing paperwork for anesthesia practices. The company's solutions are designed to deliver comprehensive and accurate case and drug data directly to clinical, revenue cycle management, pharmacy, and executive teams within healthcare organizations.
Medaxion's technology is designed to optimize operating room performance and revenue by providing real-time intelligence and enhancing productivity throughout the organization. The company holds several patents related to its mobile health solutions, including US Patent Nos. 8,326,651 B2, 8,850,533 B2, and 10,747,406 B2, with others pending.
In September 2012, Medaxion had raised approximately USD 801,000 from 13 investors, as per a regulatory filing. The company was co-founded in 2008 by Jeff McLaren, who previously co-founded HealthStream, a publicly traded healthcare education and research company based in Nashville.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.